The effect of BS6.890C in the prophylactic transplant model of psoriasis in which a psoriatic lesion is induced in non-lesional skin transplanted onto immune-deficient (BNX) mice by injecting superantigen activated peripheral blood cells intra-dermally into the transplant.

The effect of BS6.890C in the prophylactic transplant model of psoriasis in which a psoriatic lesion is induced in non-lesional skin transplanted onto immune-deficient (BNX) mice by injecting superantigen activated peripheral blood cells intra-dermally into the transplant. - The effect of BS6.890C in the transplant model of psoriasis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON41006

Enrollment

Registered

2014-08-12

Start date

2014-10-06

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

testing drugs using a humanized mouse model of psoriasis Psoriasis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with psoriasis vulgaris (light to mild)

Exclusion criteria

Exclusion criteria: Volunteers can not use systemic drugs (for their psoriasis). Volunteers cannot have UV-light therapy. Volunteers cannot use immune-modulating drugs for other diseases. Volunteers should not have problems with the Köbner phenomenon.

Design outcomes

Primary

Measure	Time frame
Not applicable.	—

Secondary

Measure	Time frame
Not applicable.	—

Countries

Netherlands

Outcome results